Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
[212Pb]PSV359
product7 mentionslast seen Nov 9, 2026
A targeted alpha-particle therapy designed to target and deliver 212 Pb to tumor sites expressing FAP-α.
Relationships 17
- Perspective Therapeutics, Inc.develops[212Pb]PSV35999% confidence7 sources
- [212Pb]PSV359applies tosolid tumor treatment99% confidence3 sources
- U.S. Food and Drug Administrationapproves[212Pb]PSV35996% confidence1 source
- [212Pb]PSV359applies toadvanced solid tumors94% confidence1 source
- [212Pb]PSV359applies tofibroblast activation protein-positive solitary fibrous tumor treatment94% confidence1 source
- [212Pb]PSV359applies tosolid tumors94% confidence1 source
- [212Pb]PSV359depends onfibroblast activation protein94% confidence1 source
- [212Pb]PSV359composed oflead-21293% confidence1 source
- [212Pb]PSV359depends onlead-21292% confidence1 source
- [212Pb]PSV359composed of212Pb92% confidence1 source
- U.S. Food and Drug Administrationapproves[212Pb]PSV35992% confidence1 source
- [212Pb]PSV359applies tofibroblast activation protein-positive solid tumor treatment91% confidence1 source
- [212Pb]PSV359applies tonon-small cell lung cancer90% confidence1 source
- [212Pb]PSV359conforms toFDA Fast Track Designation90% confidence1 source
- [212Pb]PSV359applies toFAP-α positive solid tumors90% confidence1 source
- [212Pb]PSV359applies tocolorectal cancer90% confidence1 source
- [212Pb]PSV359depends on224Ra/212Pb generator85% confidence1 source
Sources
Select a relationship to read the sources behind it.